|
|
|
|
|
searchin this issue
premium serviceseventsdirectory servicesadvertisingcustomer care |
Archives :: Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
Displaying 101 - 120 of 868 stories.
November 23, 2012
The European Commission says that Switzerland has on 22 November been listed as the first non European Union (EU) country with active pharmaceutical ingredient (API) manufacturing...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Switzerland-first-country-listed-under-new-rules-that-can-export-APIs-to-EU-without-written-confirmation_47909.html November 22, 2012
The fine chemicals division of Johnson Matthey recorded a 2.8% fall in sales in the fiscal first half ended 30 September 2012, compared with the corresponding period of the previous...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Johnson-Mattheys-fine-chemicals-division-reports-rise-in-operating-profits_47902.html November 20, 2012
Teva’s API business reports rise in sales Teva Pharmaceutical Industries (Petach Tikva, Israel), which has the largest active pharmaceutical ingredient (API) business in the...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-20-November_47853.html November 20, 2012
The total revenue generated by the Asia/Pacific active pharmaceutical ingredient (API) market was $30.69 billion in 2011, and it is expected to grow at a compound annual growth rate of...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Report-API-market-in-AsiaPacific-to-reach-$63-8-billion-by-2017_47847.html November 14, 2012
Sigma-Aldrich Fine Chemicals (SAFC), the custom manufacturing and services business unit of Sigma-Aldrich, says it has added more than 25 new raw materials to its PharmaGrade products...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SAFC-expands-raw-materials-portfolio-for-biopharmaceutical-manufacturing_47684.html November 13, 2012
EFCG says EU directive does not address API quality issues; calls for mandatory inspection of API manufacturing sites The European Fine Chemicals Group (EFCG; Brussels), an industry...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-13-November_47656.html November 13, 2012
The European Fine Chemicals Group (EFCG; Brussels), an industry association that is part of Cefic, says that the European Union's new Falsified Medicines Directive, which is designed...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/EFCG-says-EU-directive-does-not-address-API-quality-issues-calls-for-mandatory-inspection-of-API-manufacturing-sites_47654.html November 13, 2012
Lonza says it has started negotiations with the unions Syna and Unia to implement the recently announced job cuts. Lonza on 31 October announced it will cut 500 jobs globally...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Lonza-negotiates-with-unions-to-implement-job-cuts_47653.html November 12, 2012
Orchid Chemicals & Pharmaceuticals (Chennai, India), a leading Indian pharmaceutical company, says it is exiting its 50-50 active pharmaceutical ingredient (API) manufacturing...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Orchid-exits-API-jv-in-China_47632.html November 8, 2012
Watson Pharmaceuticals (Parsippany, NJ) says it has completed the previously announced acquisition of generic pharmaceuticals company Actavis (Zug, Switzerland) for €4.25 billion...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Watson-completes-acquisition-of-Actavis-for-&euro4-25-billion_47446.html November 6, 2012
Lonza to cut 500 jobs Lonza, in its business update announcement for the third quarter of 2012, says that it will make further efforts to improve the profitability of the company's...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-6-November_47471.html November 6, 2012
Hikal (Mumbai), an outsourcing partner to companies in the pharma, biotech, agchem, and specialty chemical industries, has recorded a 81.9% fall in net profits for its fiscal...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Hikal-reports-fall-in-profits_47470.html November 6, 2012
Cambrex (East Rutherford, NJ) reported a 39% fall in net profits for the third quarter, ended 30 September 2012, compared with the year-ago period, to $1.68 million. Net sales...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Cambrex-reports-fall-in-profits_47467.html November 5, 2012
The global high-potency active pharmaceutical ingredients (HPAPIs) market, which was worth $9.1 billion in 2011, is expected to reach $17.5 billion in 2018, growing at a compund annual...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Report-Global-high-potency-API-market-to-reach-$17-5-billion-in-2018_47447.html November 5, 2012
Wacker says that its Wacker Biotech (Jena, Germany) subsidiary and XL-protein (Freising, Germany), a privately owned biopharmaceutical company, have signed an agreement to collaborate...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Wacker-XL-protein-sign-cooperation-agreement-to-produce-biopharmaceuticals_47443.html October 30, 2012
Lonza chairman denies takeover discussions By Ian Young Lonza chairman Rolf Soiron has denied speculation that the company has held acquisition talks with a potential buyer for Lonza...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/PharmaFine-Chemicals-Roundup-October-30_47358.html October 30, 2012
Sigma-Aldrich Fine Chemicals (SAFC), the custom manufacturing and services business unit of Sigma-Aldrich, says it has signed an agreement with CrystalGenomics (Seoul) to support the...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/SAFC-signs-API-development-deal-with-Korean-firm_47353.html October 23, 2012
Mylan buys API plant in India Active pharmaceutical ingredients (API), intermediates and formulations manufacturer SMS Pharmaceuticals (Hyderabad, India) informed the Bombay Stock...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Pharmafine-chemicals-roundup-23-October_47147.html October 23, 2012
Active pharmaceutical ingredients (API), intermediates, and formulations manufacturer SMS Pharmaceuticals (Hyderabad, India) informed the Bombay Stock Exchange (Mumbai) that its board...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Mylan-buys-API-plant-in-India_47146.html October 23, 2012
Sinochem (Beijing) says it signed a memorandum of strategic cooperation, at Shanghai on 21 August, with PTT Global Chemical (Bangkok), Thailand's largest integrated petrochemical and...http://www.chemweek.com/markets/fine_chemicals_biotech/pharmaceutical_ingredients/Sinochem-and-PTT-Global-Chemical-sign-cooperation-deal-for-fine-chemicals-business_47140.html |
|
Connect with IHS Chemical Week |
Quick links |
Our related sites |
|
contact us | about us |
customer care |
privacy policy |
sitemap |
advertise
|
Follow us on Twitter
